Variables | HR | 95% CI | p |
---|---|---|---|
Age | |||
< 55 years | 1 | ||
≥ 55 years | 0.674 | 0.351–1.294 | 0.236 |
Sex | |||
Female | 1 | ||
Male | 1.258 | 0.694–2.282 | 0.450 |
Tumor size | |||
≤ 1 cm | 1 | ||
> 1 cm | 1.656 | 1.006–2.725 | 0.047 |
Multifocality | |||
No | 1 | ||
Yes | 1.543 | 0.929–2.562 | 0.094 |
Bilaterality | |||
No | 1 | ||
Yes | 1.115 | 0.624–1.995 | 0.713 |
LVI | |||
No | 1 | ||
Yes | 0.891 | 0.515–1.543 | 0.891 |
CLT | |||
No | 1 | ||
Yes | 0.891 | 0.515–1.543 | 0.681 |
T stage | |||
T1/2/3a | 1 | ||
T3b | 1.013 | 0.432–2.376 | 0.976 |
T4a | 4.019 | 2.079–7.773 | < 0.001 |
ETE | |||
No gross ETE | 1 | ||
Gross ETE | 1.964 | 1.124–3.433 | 0.018 |
Harvested LN | |||
≤ 4 | 1 | ||
≥ 5 | 0.613 | 0.372–1.010 | 0.055 |
Positive LN | |||
≤ 2 | 1 | ||
≥ 3 | 2.606 | 1.577–4.306 | < 0.001 |
LN ratio | |||
≤ 0.5 | 1 | ||
> 0.5 | 4.992 | 2.791–8.928 | < 0.001 |
TNM stage | |||
Stage I | 1 | ||
Stage II/III | 0.507 | 0.184–1.398 | 0.189 |